The International Medical Device Regulators Forum (IMDRF) has released a new strategic plan outlining its priorities for the next five years, signaling a continued emphasis on global regulatory convergence, deeper stakeholder engagement, and internal governance reform. The plan, which covers the 2026–2030 period, reflects IMDRF’s rapid growth and its evolving role in shaping international medical device regulation.
As global regulatory coordination becomes increasingly important for medical device manufacturers, IMDRF’s updated strategy offers insight into how international expectations may continue to align across markets.
Managing Growth and Organizational Sustainability
IMDRF noted that its membership has expanded significantly in recent years, growing from fewer than 20 members to nearly 50. With continued expansion expected, the organization identified long-term sustainability and leadership development as core priorities.
To address these challenges, IMDRF plans to modernize its governance framework. This includes tasking its governance subcommittee with proposing a revised governance structure and updating standard operating procedures to clarify committee roles, decision-making processes, and executive responsibilities. These changes are intended to ensure IMDRF can continue operating efficiently while supporting a broader and more diverse membership.
Reinforcing Foundational Regulatory Principles
Another key focus of the strategic plan is reinforcing IMDRF’s foundational principles, many of which originated under its predecessor organization, the Global Harmonization Task Force (GHTF). IMDRF plans to review legacy GHTF documents that remain foundational to global device regulation and update them into formal IMDRF guidance where appropriate.
This effort is expected to strengthen consistency across international regulatory frameworks while ensuring that guidance remains relevant to modern technologies and regulatory challenges.
Expanding Stakeholder and Industry Engagement
A central theme of the plan is increased engagement with stakeholders, particularly the medical technology industry. IMDRF emphasized the importance of collaboration to strike the right balance between regulatory oversight and timely patient access to medical devices.
The organization highlighted its intent to continue engaging industry through the IMDRF Industry Group, joint workshops, and bilateral meetings. In addition, IMDRF plans to broaden outreach by identifying new stakeholder groups, expanding opportunities for participation in New Work Item Proposals, and exploring new mechanisms for dialogue on shared regulatory challenges.
IMDRF emphasized that efficient, transparent, and risk-based regulatory processes are critical to reducing delays in patient access, particularly for innovative and high-priority medical devices.
Implications for Medical Device Manufacturers
IMDRF’s strategic direction reinforces the growing importance of global regulatory alignment, early stakeholder engagement, and proactive participation in international regulatory initiatives. Manufacturers operating across multiple regions should anticipate continued convergence efforts and evolving expectations tied to IMDRF guidance and working group outputs.
Active monitoring of IMDRF activities and early engagement with emerging work items will be increasingly important for organizations seeking to anticipate regulatory change rather than react to it.
How EMMA International Supports Global Device Strategy
At EMMA International, we help medical device and IVD manufacturers navigate global regulatory convergence, including alignment with IMDRF principles, participation in international regulatory initiatives, and strategic planning across FDA, EU, and global markets. Our teams support regulatory intelligence, governance alignment, and stakeholder engagement strategies to help organizations stay ahead of evolving global expectations.
For more information on how EMMA International can assist, visit www.emmainternational.com or contact us at (248) 987-4497 or info@emmainternational.com.
Reference:
International Medical Device Regulators Forum. IMDRF Strategic Plan 2026–2030. December 2025.
Regulatory Affairs Professionals Society. IMDRF emphasizes engagement, governance reform in new strategic plan. January 6, 2026.
International Medical Device Regulators Forum. Overview of IMDRF governance and stakeholder engagement activities.
